Nader Naeymi-Rad Appointed Chief Operating Officer at Campbel... (e information onCampbell Alliance please...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance

Date:8/7/2008

e information on Campbell Alliance, please visit http://www.campbellalliance.com .

CONTACT:

James Forte

Director, Public and Media Relations

Campbell Alliance

+1 919 844 7100, extension 7195

jforte@campbellalliance.com

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
3. John Marshall and Kevin McGuinness Appointed to Ellex Board
4. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
5. David Mott Appointed Non Executive Director at Shire
6. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
7. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
8. Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
9. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
10. Chris Tihansky Appointed President of In Vivo Cellular Imaging Leader Cellvizio Inc.
11. Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center

Post Your Comments:

Breaking Biology Technology:EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2 Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2 Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6 Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2

[0] EUCODIS Bioscience Appoints Thomas Fischer as New CEO [0] Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. [0] RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE)[0] Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)

Other Biology Technology:Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health Canada 2

Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health Canada Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008 DURECT Corporation to Participate in Upcoming Healthcare Conferences

Breaking Biology News(10 mins):$2.4 million stimulus fuels effort to regenerate injured spinal cords 2 $2.4 million stimulus fuels effort to regenerate injured spinal cords 3 $2.4 million stimulus fuels effort to regenerate injured spinal cords 4 Delivering medicine directly into a tumor 2 Improving the odds 2 Intensive care units poorly equipped to care for the dying 58854 1 Intensive care units poorly equipped to care for the dying 58854 2 Focused Radiation Protects Tumor Patients Brain Function 58850 1 Focused Radiation Protects Tumor Patients Brain Function 58850 2 As Schools Reopen in Indonesia World Vision Says Childrens Basic Needs Still Not Being Met 58845 1 As Schools Reopen in Indonesia World Vision Says Childrens Basic Needs Still Not Being Met 58845 2

[0] $2.4 million stimulus fuels effort to regenerate injured spinal cords [0] Delivering medicine directly into a tumor [0] Improving the odds

Other Biology News:Discovery of new cave millipedes casts light on Arizona cave ecology 2 Discovery of new cave millipedes casts light on Arizona cave ecology 3 Leeches ferry infection among newts 2 Rare cell prevents rampant brain activity 2

Discovery of new cave millipedes casts light on Arizona cave ecology Leeches ferry infection among newts Rare cell prevents rampant brain activity

Biology Products:

Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology Mouse Anti-Mouse Ly 6C.2(Ly 28.2) Monoclonal Antibody, Unconjugated, Clone 5075-3.6 from CEDARLANE Laboratories Limited Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology